LBLuisa Monteiro Burin

Luisa Monteiro Burin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luisa Monteiro Burin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Agna A. Bartels-Velthuis

    University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, Groningen, The Netherlands

    1 shared publication
  • Bjørn Hylsebeck Ebdrup

    Center for Neuropsychiatric Schizophrenia Research, CNSR, and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Center Glostrup, Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Glostrup, Denmark

    1 shared publication
  • Claudia J. P. Simons

    Department of Psychiatry and Neuropsychology, Mental Health and Neuroscience Research Institute, Maastricht University, Vijverdalseweg 1, 6226 NB Maastricht, The Netherlands

    1 shared publication
  • Cleonice Zatti

    Graduate Program in Psychiatry and Behavioral Sciences, UFRGS: Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil, Brazil

    1 shared publication
  • Femin Prasad

    Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada

    1 shared publication
  • Filip Krag Knop

    Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

    1 shared publication

Latest Publications

  • Open Access

    Association between attachment style and suicide risk in patients receiving online psychotherapy: a cross-sectional study of five psychotherapy services

    by Cleonice Zatti, Luisa Monteiro Burin, Neusa Sica Da Rocha

    Background: Restrictions imposed during the COVID-19 pandemic have raised concern among suicidology and mental health researchers regarding a possible increase in suicide risk, particularly among people already in psychological distress. Attachment style is one relational characteristic that may act as either a vulnerability or a protective factor. Objective: To analyze the association between attachment style and suicide risk among patients undergoing online psychotherapy. Additionally, it sought to explore the influence of depression on this relationship and to estimate the prevalence of suicide risk. Method: Cross-sectional analysis of a multi-center sample of patients in online psychotherapy during the COVID-19 pandemic ( n = 94) with complete data on all instruments analyzed. Measures included sociodemographic data, attachment style (Adult Attachment Scale-R, AAS-R), depression (PHQ-9), and suicide risk (PHQ-9-item9). Group comparisons used the Mann-Whitney U test; associations used the chi-square test, and relationships between scores used Spearman correlations. Results: The prevalence of higher suicide risk was 43.6% ( n = 41; 95% CI 34.0–53.7). Patients at higher suicide risk scored higher on anxiety/fear of abandonment (3.53 ± 0.99 vs. 3.03 ± 1.04; p = .018; r = .28) and lower on comfort with intimacy (2.88 ± 0.82 vs. 3.44 ± 0.73; p = .003; r = − .36) and trust in others (2.54 ± 0.76 vs. 2.87 ± 0.68; p = .044; r = − .24). Depression severity fully mediated the effects of comfort with intimacy and trust in others on suicide risk, but not that of anxiety/fear of abandonment. Conclusions: Attachment style was associated with suicide risk in patients receiving online psychotherapy. Much, though not all, of this association operated through depression severity. The findings support the early identification of insecure attachment as a clinically useful component of suicide risk assessment and underline that suicidal ideation is not confined to patients who screen positive for depression.

  • Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review

    by Riddhita De, Femin Prasad, Nicolette Stogios, Luisa Burin, Bjørn H. Ebdrup, Filip K. Knop, Margaret K. Hahn, Sri Mahavir Agarwal

    IntroductionPsychotropic medications, especially antipsychotics, have been consistently shown to cause weight gain in individuals with severe mental illness (SMI), a population inherently challenged by poor physical health. Consequently, compared to the general population, this contributes to an increased cardiometabolic burden, including the risk of type 2 diabetes, dyslipidemia, and hypertension. Furthermore, comorbid obesity leads to treatment nonadherence, decreased quality of life, and increased risk of relapse, posing a challenge in the management of mental health. To address this, emerging agents investigated in the general population with potential to mitigate weight gain were explored to assess translatability to the SMI population.Areas coveredA literature search was conducted including agents approved for the management of obesity in the general population, along with upcoming agents under investigation in phase III trials with weight loss properties.Expert opinionMetformin and topiramate along with lifestyle interventions are commonly prescribed for weight gain in individuals with SMI; however, their weight loss potential is modest at best. This review identified tirzepatide and cagrilintide-semaglutide among others as promising agents for adjunctive pharmacological management of weight gain.


  • Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study

    by Luisa M. Burin, Margaret K. Hahn, Neusa S. da Rocha, Therese van Amelsvoort, Agna A. Bartels-Velthuis, Richard Bruggeman, Lieuwe de Haan, Frederike Schirmbeck, Claudia J.P. Simons, Jim van Os, et al.